Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2011

01.01.2011 | Original Article

Fluticasone and Food Allergen Elimination Reverse Sub-epithelial Fibrosis in Children with Eosinophilic Esophagitis

verfasst von: Samer M. A. Abu-Sultaneh, Paul Durst, Virginia Maynard, Yoram Elitsur

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Symptoms of vomiting and dysphagia in children with eosinophilic esophagitis may be related to the development of mucosal fibrosis.

Aim

Our aims were to (1) investigate esophageal fibrosis in children with EoE compared to patients with gastroesophageal reflux disease and normal individuals, and (2) to assess the degree of mucosal fibrosis in patients with EoE before and after medical treatment.

Methods

A retrospective analysis of esophageal biopsies from patients with EoE, GERD, and normal mucosa was performed. Demographic data, clinical information, eosinophil number, and sub-epithelial fibrosis was compared among the groups. A similar comparison was performed in EoE patients, before and after therapy.

Results

Esophageal biopsies from 53 children were included, of which 17 with EoE, 17 GERD, and 19 were normal. A significantly higher number of eosinophils and greater fibrosis was found in EoE patients vs. GERD and normal (fibrosis grade 2: 13 patients in the EoE group vs. one patient for each control group; p = 0.0001). After therapy, a significant decrease in fibrosis and eosinophils number was noted in EoE patients [fibrosis grade 2: 10 (71.5%) patients vs. one (7.1%) patient, and eosinophil count was 35.5/HPF vs. 13.4/HPF, pre- and post-therapy, respectively; p < 0.05]. The decrease in esophageal fibrosis paralleled the improvement in the related clinical symptoms.

Conclusion

A higher degree of esophageal fibrosis was found in patients with EoE compared to GERD or normal esophagus. Conventional therapy in EoE improved obstructive symptoms, decreased eosinophils count, and reversed the degree of fibrosis. We suggest that appropriate therapy in patients with EoE will improve clinical symptoms and histology.
Literatur
1.
Zurück zum Zitat Liacouras CA, Bonis P, Putnam PE, et al. Summary of the first International Gastrointestinal Eosinophil Research Symposium. J Pediatr Gastroenterol Nutr. 2007;45:370–391.CrossRefPubMed Liacouras CA, Bonis P, Putnam PE, et al. Summary of the first International Gastrointestinal Eosinophil Research Symposium. J Pediatr Gastroenterol Nutr. 2007;45:370–391.CrossRefPubMed
2.
Zurück zum Zitat Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systemic review and consensus recommendations for diagnosis and treatment. The First International Gastrointestinal Eosinophil Research Symposium. Gastroenterology. 2007;133(4):1342–1363.CrossRefPubMed Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systemic review and consensus recommendations for diagnosis and treatment. The First International Gastrointestinal Eosinophil Research Symposium. Gastroenterology. 2007;133(4):1342–1363.CrossRefPubMed
3.
Zurück zum Zitat Lucendo AJ, Pascual-Turrion JM, Navarro M, et al. Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy. 2007;39:765–771.CrossRefPubMed Lucendo AJ, Pascual-Turrion JM, Navarro M, et al. Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy. 2007;39:765–771.CrossRefPubMed
4.
Zurück zum Zitat Fox VL, Nurko S, Teitelbaum JE, et al. High-resolution EUS in children with eosinophilic “allergic” esophagitis. Gastrointest Endosc. 2003;57:30–36.CrossRefPubMed Fox VL, Nurko S, Teitelbaum JE, et al. High-resolution EUS in children with eosinophilic “allergic” esophagitis. Gastrointest Endosc. 2003;57:30–36.CrossRefPubMed
5.
Zurück zum Zitat Chehade M, Sampson HA, Morotti RA, et al. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:319–328.CrossRefPubMed Chehade M, Sampson HA, Morotti RA, et al. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:319–328.CrossRefPubMed
6.
Zurück zum Zitat Aceves SS, Newbury RO, Dohil R, et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119:206–212.CrossRefPubMed Aceves SS, Newbury RO, Dohil R, et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119:206–212.CrossRefPubMed
7.
Zurück zum Zitat Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, Bastian JF, Broide DH. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2009. [Epub ahead of print]. Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H, Bastian JF, Broide DH. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2009. [Epub ahead of print].
8.
Zurück zum Zitat The non-neoplastic esophagus. In: Fenoglio-Preiser CM et al., eds. Gastrointestinal pathology: an atlas and text, 3rd edn. Philadelphia: Lippincott-Williams & Wilkin; 2008. The non-neoplastic esophagus. In: Fenoglio-Preiser CM et al., eds. Gastrointestinal pathology: an atlas and text, 3rd edn. Philadelphia: Lippincott-Williams & Wilkin; 2008.
9.
Zurück zum Zitat Khan S, Orenstein SR, Di Lorenzo C, et al. Eosinophilic esophagitis: strictures, impactions, dysphagia. Dig Dis Sci. 2003;48:22–29.CrossRefPubMed Khan S, Orenstein SR, Di Lorenzo C, et al. Eosinophilic esophagitis: strictures, impactions, dysphagia. Dig Dis Sci. 2003;48:22–29.CrossRefPubMed
10.
Zurück zum Zitat Odze RD. Pathology of eosinophilic esophagitis: what the clinician needs to know. Am J Gastroenterol. 2009;104:485–490.CrossRefPubMed Odze RD. Pathology of eosinophilic esophagitis: what the clinician needs to know. Am J Gastroenterol. 2009;104:485–490.CrossRefPubMed
11.
Zurück zum Zitat Teitelbaum JE, Fox VL, Twarog FJ, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002;122:1216–1225.CrossRefPubMed Teitelbaum JE, Fox VL, Twarog FJ, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002;122:1216–1225.CrossRefPubMed
12.
Zurück zum Zitat Shah A, Hirano I. Treatment of eosinophilic esophagitis: drugs, diet, or dilatation? Curr Gastroenterol Rep. 2007;9:181–188.CrossRefPubMed Shah A, Hirano I. Treatment of eosinophilic esophagitis: drugs, diet, or dilatation? Curr Gastroenterol Rep. 2007;9:181–188.CrossRefPubMed
13.
Zurück zum Zitat Gupta SK, Fitzgerald JF, Kondratyuk T, et al. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42:22–26.CrossRefPubMed Gupta SK, Fitzgerald JF, Kondratyuk T, et al. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42:22–26.CrossRefPubMed
14.
Zurück zum Zitat Aceves SS, Ackerman S. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis ineosinophilic esophagitis. Immunol Allergy Clin N Am. 2009;29:197–211.CrossRef Aceves SS, Ackerman S. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis ineosinophilic esophagitis. Immunol Allergy Clin N Am. 2009;29:197–211.CrossRef
15.
Zurück zum Zitat Maples KM, Henderson SC, Graham M, et al. Treatment of eosinophilic esophagitis with inhaled budesonide in a 7-year-old boy with concomitant persistent asthma: resolution of esophageal submucosal fibrosis and eosinophilic infiltration. Ann Allergy Asthma Immunol. 2007;99:572–574.CrossRefPubMed Maples KM, Henderson SC, Graham M, et al. Treatment of eosinophilic esophagitis with inhaled budesonide in a 7-year-old boy with concomitant persistent asthma: resolution of esophageal submucosal fibrosis and eosinophilic infiltration. Ann Allergy Asthma Immunol. 2007;99:572–574.CrossRefPubMed
16.
Zurück zum Zitat Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility in glucocorticoids. J Allergy Clin Immunol. 2007;120:1292–1300.CrossRefPubMed Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility in glucocorticoids. J Allergy Clin Immunol. 2007;120:1292–1300.CrossRefPubMed
17.
Zurück zum Zitat Pentiuk S, Putnam PE, Collins MH, Rothenberg M. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediat Gastroentrol Nutr. 2009;48:152–160.CrossRef Pentiuk S, Putnam PE, Collins MH, Rothenberg M. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediat Gastroentrol Nutr. 2009;48:152–160.CrossRef
18.
Zurück zum Zitat Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660–1669.CrossRefPubMed Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660–1669.CrossRefPubMed
19.
Zurück zum Zitat Nago P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus: peptic or allergic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101:1666–1670.CrossRef Nago P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus: peptic or allergic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101:1666–1670.CrossRef
20.
Zurück zum Zitat Molina-Infante J, Ferrando-Lamana L, Mateos Rodriguez JM, et al. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol. 2008;14:1463–1466.CrossRefPubMed Molina-Infante J, Ferrando-Lamana L, Mateos Rodriguez JM, et al. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol. 2008;14:1463–1466.CrossRefPubMed
21.
Zurück zum Zitat Molina-Infante J, Ferrando-Lamana L, Fernandez-Bermejo M, Porcel-Carreno S. Eosinophilic esophagitis in GERD patients: a clinic-pathological diagnosis using proton pump inhibitors. Am J Gastroenterol. 2009;104:2856–2857.CrossRefPubMed Molina-Infante J, Ferrando-Lamana L, Fernandez-Bermejo M, Porcel-Carreno S. Eosinophilic esophagitis in GERD patients: a clinic-pathological diagnosis using proton pump inhibitors. Am J Gastroenterol. 2009;104:2856–2857.CrossRefPubMed
22.
Zurück zum Zitat Dubecz A, Mentrikoski M, Peter JH. Eosinophilic esophagitis with severe GERD. Am J Gastorentrol. 2009;104:527–529.CrossRef Dubecz A, Mentrikoski M, Peter JH. Eosinophilic esophagitis with severe GERD. Am J Gastorentrol. 2009;104:527–529.CrossRef
Metadaten
Titel
Fluticasone and Food Allergen Elimination Reverse Sub-epithelial Fibrosis in Children with Eosinophilic Esophagitis
verfasst von
Samer M. A. Abu-Sultaneh
Paul Durst
Virginia Maynard
Yoram Elitsur
Publikationsdatum
01.01.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1259-5

Weitere Artikel der Ausgabe 1/2011

Digestive Diseases and Sciences 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.